Last $1.44 USD
Change Today +0.03 / 2.13%
Volume 303.9K
ATHX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - athersys inc (ATHX)

Name (Connections)Board RelationshipsTitleKey Developments
Lorin Randall 75 RelationshipsDirector, Chairman of Audit Committee, Chairman of Compensation Committee and Member of Nominations & Corporate Governance CommitteeAthersys, Inc. announced delayed 10-Q filing
08/14/07
Jack Wyszomierski 47 RelationshipsDirector, Member of Nominations & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee 
Kenneth Traub 46 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee 

Compensation Committee* - athersys inc (ATHX)

Name (Connections)Board RelationshipsTitle
Lee Babiss Ph.D. 229 RelationshipsLead Director, Member of Nominations & Corporate Governance Committee and Member of Compensation Committee
Lorin Randall 75 RelationshipsDirector, Chairman of Audit Committee, Chairman of Compensation Committee and Member of Nominations & Corporate Governance Committee
Kenneth Traub 46 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee
Jack Wyszomierski 47 RelationshipsDirector, Member of Nominations & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
ATHX Compensation vs. Industry
450.0K
361.4K
Chief Executive Officer
239.3K
267.8K
Chief Financial Officer
371.4K
348.3K
Chief Operating Officer
Share price activity for ATHERSYS INC (ATHX)
52 Week Price Performance
ATHX
Industry Average

Nominating Committee* - athersys inc (ATHX)

Name (Connections)Board RelationshipsTitleKey Developments
Lorin Randall 75 RelationshipsDirector, Chairman of Audit Committee, Chairman of Compensation Committee and Member of Nominations & Corporate Governance CommitteeFloyd Loop Resigns as Board of Director of Athersys, Inc
01/3/11
Lee Babiss Ph.D. 229 RelationshipsLead Director, Member of Nominations & Corporate Governance Committee and Member of Compensation CommitteeAthersys, Inc. Appoints Ismail Kola, as Director
10/19/10
Jack Wyszomierski 47 RelationshipsDirector, Member of Nominations & Corporate Governance Committee, Member of Audit Committee and Member of Compensation CommitteeMichael Sheffery to Resign as a Member of Athersys' Board of Directors
09/10/10
Ismail Kola Ph.D. 69 RelationshipsDirector and Member of Nominations & Corporate Governance CommitteeAthersys, Inc. Elects Dr. Lee E. Babiss as Director and to the Nominations Committee
08/9/10

Corporate Governance Committee* - athersys inc (ATHX)

Name (Connections)Board RelationshipsTitle
Lee Babiss Ph.D. 229 RelationshipsLead Director, Member of Nominations & Corporate Governance Committee and Member of Compensation Committee
Ismail Kola Ph.D. 69 RelationshipsDirector, Chairman of Audit Committee, Chairman of Compensation Committee and Member of Nominations & Corporate Governance Committee
Lorin Randall 75 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee
Jack Wyszomierski 47 RelationshipsDirector, Member of Nominations & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
ATHX and Competitor
Insiders vs. External
Board
8%
92%
Athersys, Inc.
13%
87%
Vericel Corporation
13%
87%
Cytori Therapeutics, Inc.
11%
89%
StemCells Inc.
7%
93%
Bioheart, Inc.
9%
91%
Pluristem Therapeutics, Inc.
Insiders
External Board Members

Advisory Committee* - athersys inc (ATHX)

Name (Board Relationships)/Title Board Affiliations
Brian Annex 34 Relationships
Scientific and Clinical Advisor
No other board affiliations
C. Thomas Caskey 78 Relationships
Scientific and Clinical Advisor
No other board affiliations
Gilbert Clincke 24 Relationships
Scientific and Clinical Advisor
No other board affiliations
David Hess 24 Relationships
Scientific and Clinical Advisor
No other board affiliations
Robert Kushner 32 Relationships
Scientific and Clinical Advisor
No other board affiliations
Hillard Lazarus 44 Relationships
Scientific & Clinical Advisor
No other board affiliations
Richard Maziarz 24 Relationships
Scientific & Clinical Advisor
No other board affiliations
Ira Mellman 152 Relationships
Scientific and Clinical Advisor
No other board affiliations
Marc Penn 140 Relationships
Scientific and Clinical Advisor
No other board affiliations
F. Pi-Sunyer 84 Relationships
Scientific and Clinical Advisor
No other board affiliations
Warren Sherman 89 Relationships
Scientific and Clinical Advisor
No other board affiliations
James Shook 24 Relationships
Scientific and Clinical Advisor
No other board affiliations
Jerry Silver 43 Relationships
Scientific and Clinical Advisor
No other board affiliations
Michael Simons 38 Relationships
Scientific and Clinical Advisor
No other board affiliations
Catherine Verfaillie 24 Relationships
Scientific and Clinical Advisor
No other board affiliations
John Wagner 24 Relationships
Scientific & Clinical Advisor
No other board affiliations
Larry Wechsler 24 Relationships
Scientific and Clinical Advisor
No other board affiliations
Huntington Willard 24 Relationships
Scientific and Clinical Advisor
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATHX:US $1.44 USD +0.03

ATHX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bioheart Inc $0.02 USD 0.0001
Cytori Therapeutics Inc $0.44 USD +0.0179
Pluristem Therapeutics Inc $2.61 USD +0.03
StemCells Inc $1.13 USD -0.01
Vericel Corp $2.84 USD +0.065
View Industry Companies
 

Industry Analysis

ATHX

Industry Average

Valuation ATHX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 47.2x
Price/Book 4.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 33.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERSYS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.